Countries with high rates of missed hemodialysis (HD) treatments have elevated rates of death and other adverse outcomes, reports a study in American Journal of Kidney Diseases.
The researchers analyzed data on 8501 patients in 20 countries participating in the international Dialysis Outcomes and Practice Patterns Study (DOPPS). All patients had been on HD therapy for longer than 120 days. The 4-month missed treatment rate varied from less than 1% in Italy and Japan to 24% in the United States.
After exclusion of patients from six countries with 4-month missed treatment rates of less than 5%, longitudinal and